Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series

Hypertension impacts overall prognosis in cancer patients. There are no specific recommendations for its management in these patients. We report a case series of 5 cancer patients with suboptimal BP lowering and even worsening BP with ACEi or ARBs that improved to normal upon discontinuation of thes...

Descripción completa

Detalles Bibliográficos
Autores principales: Goel, Mishita, Varandani, Rajiv Sunil, Okwuosa, Tochukwu M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450561/
https://www.ncbi.nlm.nih.gov/pubmed/32864163
http://dx.doi.org/10.1186/s40959-020-00071-x
_version_ 1783574827932581888
author Goel, Mishita
Varandani, Rajiv Sunil
Okwuosa, Tochukwu M.
author_facet Goel, Mishita
Varandani, Rajiv Sunil
Okwuosa, Tochukwu M.
author_sort Goel, Mishita
collection PubMed
description Hypertension impacts overall prognosis in cancer patients. There are no specific recommendations for its management in these patients. We report a case series of 5 cancer patients with suboptimal BP lowering and even worsening BP with ACEi or ARBs that improved to normal upon discontinuation of these drugs.
format Online
Article
Text
id pubmed-7450561
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74505612020-08-28 Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series Goel, Mishita Varandani, Rajiv Sunil Okwuosa, Tochukwu M. Cardiooncology Short Communication Hypertension impacts overall prognosis in cancer patients. There are no specific recommendations for its management in these patients. We report a case series of 5 cancer patients with suboptimal BP lowering and even worsening BP with ACEi or ARBs that improved to normal upon discontinuation of these drugs. BioMed Central 2020-08-27 /pmc/articles/PMC7450561/ /pubmed/32864163 http://dx.doi.org/10.1186/s40959-020-00071-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Short Communication
Goel, Mishita
Varandani, Rajiv Sunil
Okwuosa, Tochukwu M.
Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series
title Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series
title_full Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series
title_fullStr Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series
title_full_unstemmed Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series
title_short Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series
title_sort resistance to antihypertensive drugs targeting renin-angiotensin-aldosterone-system in cancer patients: a case series
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450561/
https://www.ncbi.nlm.nih.gov/pubmed/32864163
http://dx.doi.org/10.1186/s40959-020-00071-x
work_keys_str_mv AT goelmishita resistancetoantihypertensivedrugstargetingreninangiotensinaldosteronesystemincancerpatientsacaseseries
AT varandanirajivsunil resistancetoantihypertensivedrugstargetingreninangiotensinaldosteronesystemincancerpatientsacaseseries
AT okwuosatochukwum resistancetoantihypertensivedrugstargetingreninangiotensinaldosteronesystemincancerpatientsacaseseries

Ejemplares similares